Division of HIV, ID, and Global Medicine, Department of Medicine, UCSF, San Francisco, CA.
Centre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
J Acquir Immune Defic Syndr. 2020 Dec 15;85(5):571-578. doi: 10.1097/QAI.0000000000002508.
BACKGROUND: HIV differentiated service delivery (DSD) models are scaling up in resource-limited settings for stable patients; less is known about DSD outcomes for patients with viremia. We evaluated the effect on viral suppression (VS) of a streamlined care DSD model implemented in the SEARCH randomized universal test and treat trial in rural Uganda and Kenya (NCT:01864603). METHODS: We included HIV-infected adults at baseline (2013) who were country guideline antiretroviral therapy (ART) eligible (prior ART experience or CD4 ≤ 350) with ≥1 HIV clinic visit between 2013 and 2017 in SEARCH communities randomized to intervention (N = 16) or control (N = 16). We assessed the effect of streamlined care in intervention community clinics (patient-centered care, increased appointment spacing, improved clinic access, reminders, and tracking) on VS at 3 years. Analysis was stratified by the baseline care status: ART-experienced with viremia, ART-naïve with CD4 ≤ 350, or ART-experienced with VS. RESULTS: Among 6190 ART-eligible persons in care, year 3 VS was 90% in intervention and 87% in control arms (RR 1.03, 95% CI: 1.01 to 1.06). Among ART-experienced persons with baseline viremia, streamlined care was associated with higher VS (67% vs 47%, RR 1.41, 95% CI: 1.05 to 1.91). Among ART-naïve persons, VS was not significantly higher with streamlined care (83% vs 79%, RR 1.05, 95% CI: 0.95 to 1.16). Among ART-experienced persons with baseline VS, nearly all remained virally suppressed in both arms (97% vs 95%, RR 1.01, 95% CI: 1.00 to 1.03). CONCLUSIONS: Streamlined care was associated with higher viral suppression among ART-experienced patients with viremia in this randomized evaluation of ART-eligible patients who were in care after universal HIV testing.
背景:在资源有限的环境中,艾滋病毒差异化服务提供(DSD)模式正在为稳定患者扩大规模;对于病毒载量阳性的患者,DSD 结果知之甚少。我们评估了在乌干达和肯尼亚农村的 SEARCH 随机普遍检测和治疗试验中实施的简化护理 DSD 模型对病毒抑制(VS)的影响(NCT:01864603)。
方法:我们纳入了 2013 年基线时感染 HIV 的成年人,他们符合国家抗逆转录病毒治疗(ART)指南标准(既往 ART 经验或 CD4 ≤ 350),在 SEARCH 社区中至少有 1 次 2013 年至 2017 年期间的 HIV 就诊,并随机分配到干预组(n = 16)或对照组(n = 16)。我们评估了干预社区诊所中简化护理(以患者为中心的护理、增加预约间隔、改善诊所就诊、提醒和跟踪)对 3 年时 VS 的影响。分析按基线护理状况分层:有病毒血症的 ART 经验丰富、CD4 ≤ 350 的无 ART 经验、或 VS 的有 ART 经验。
结果:在 6190 名符合 ART 条件的患者中,第 3 年的 VS 在干预组为 90%,对照组为 87%(RR 1.03,95%CI:1.01 至 1.06)。在基线病毒血症的有 ART 经验的人群中,简化护理与更高的 VS 相关(67% 对 47%,RR 1.41,95%CI:1.05 至 1.91)。在无 ART 经验的人群中,简化护理并不能显著提高 VS(83% 对 79%,RR 1.05,95%CI:0.95 至 1.16)。在基线 VS 的有 ART 经验的人群中,几乎所有患者在两个臂中都保持病毒抑制(97% 对 95%,RR 1.01,95%CI:1.00 至 1.03)。
结论:在这项对接受普遍 HIV 检测后接受护理的符合 ART 条件的患者的随机评估中,在资源有限的环境中,针对病毒血症的有 ART 经验的患者实施简化护理与更高的病毒抑制率相关。
J Acquir Immune Defic Syndr. 2020-12-15
J Acquir Immune Defic Syndr. 2024-1-1
J Acquir Immune Defic Syndr. 2020-5-1
N Engl J Med. 2019-7-18
BMC Public Health. 2019-5-6
J Acquir Immune Defic Syndr. 2019-4-1